Showing results (71-80 of 127) with videos related to
Sort By:
Pageof 13
The Cochrane Database of Systematic Reviews|September 11, 2018
Antigen-specific active immunotherapy for ovarian cancerSterre T Paijens, Ninke Leffers, Toos Daemen, et al.Journal for Immunotherapy of Cancer|September 21, 2023
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFREmily Maria Ploeg, Douwe Freerk Samplonius, Xiao Xiong, et al.Cancers|July 9, 2022
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR SignalingVrouyr Bilemjian, Martijn R Vlaming, Jimena Álvarez Freile, et al.International Journal of Cancer|April 12, 2002
Tumor-targeted immune complex formation: effects on myeloid cell activation and tumor-directed immune cell migrationBart-Jan Kroesen, Pamela M J McLaughlin, Petra H L Schuilenga-Hut, et al.Cancer Letters|August 31, 2021
Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesiclesEmily M Ploeg, Xiurong Ke, Isabel Britsch, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2013
In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imagingAnna A Rybczynska, Marco de Bruyn, Nisha K Ramakrishnan, et al.Amino Acids|July 27, 2012
Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancerZilin Yu, Giuseppe Carlucci, Hildo J K Ananias, et al.Immunologic Research|June 25, 2025
High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosisNienke Visser, Nisha K van der Meer, Yuan He, et al.Current Pharmaceutical Design|February 26, 2013
An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targetingZilin Yu, Hildo J K Ananias, Giuseppe Carlucci, et al.Frontiers in Immunology|August 10, 2023
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeuticsJimena Álvarez Freile, Yuzhu Qi, Lisa Jacob, et al.Pageof 13